NL-OMON22744尚未招募不适用
Hypofractionated irradiation for Prostate cancer.<br>Improving 5-year relapse free survival without increasing toxicity.
Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, Netherlands Cancer Institute, Amsterdam0 个研究点目标入组 800 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 800
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histologically proven adenocarcinoma of
- •the prostate
排除标准
- •1. Pretreatment PSA >/= 60 µg/l
- •2. Previous irradiation in the pelvic region or radical prostatectomy
研究者
相似试验
已完成
3 期
HYpofractionated irradiation for PROstate cancer: a randomised multicentre phase III studyProstate cancerCancerISRCTN85138529Erasmus Medical Center (The Netherlands)800
已完成
不适用
Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate CancerHigh Risk Prostate CancerNCT02107287Sergio Faria105
已完成
不适用
Short Course Radiotherapy for Localized Prostate CancerAdenocarcinoma of ProstateNCT03518853Tata Medical Center30
已完成
不适用
Hypofractionated Radiotherapy for Prostate CancerProstate CancerNCT03851926Consorci Sanitari de Terrassa300
已完成
2 期
Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)Prostatic NeoplasmsNCT00855647Stanford University99,999